Yutong Tu, Qian Yu, Mengna Li, Lixin Gao, Jialuo Mao, Jingkun Ma, Xiaowu Dong, Jinxin Che, Chong Zhang, Linghui Zeng, Huajian Zhu, Jiaan Shao, Jingli Hou, Liming Hu, Bingbing Wan, Jia Li, Yubo Zhou, Jiankang Zhang. DiPTAC: A degradation platform via directly targeting proteasomeJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 661-664. DOI: 10.1016/j.apsb.2024.09.003
|
Citation:
|
Yutong Tu, Qian Yu, Mengna Li, Lixin Gao, Jialuo Mao, Jingkun Ma, Xiaowu Dong, Jinxin Che, Chong Zhang, Linghui Zeng, Huajian Zhu, Jiaan Shao, Jingli Hou, Liming Hu, Bingbing Wan, Jia Li, Yubo Zhou, Jiankang Zhang. DiPTAC: A degradation platform via directly targeting proteasomeJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 661-664. DOI: 10.1016/j.apsb.2024.09.003
|
Yutong Tu, Qian Yu, Mengna Li, Lixin Gao, Jialuo Mao, Jingkun Ma, Xiaowu Dong, Jinxin Che, Chong Zhang, Linghui Zeng, Huajian Zhu, Jiaan Shao, Jingli Hou, Liming Hu, Bingbing Wan, Jia Li, Yubo Zhou, Jiankang Zhang. DiPTAC: A degradation platform via directly targeting proteasomeJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 661-664. DOI: 10.1016/j.apsb.2024.09.003
|
Citation:
|
Yutong Tu, Qian Yu, Mengna Li, Lixin Gao, Jialuo Mao, Jingkun Ma, Xiaowu Dong, Jinxin Che, Chong Zhang, Linghui Zeng, Huajian Zhu, Jiaan Shao, Jingli Hou, Liming Hu, Bingbing Wan, Jia Li, Yubo Zhou, Jiankang Zhang. DiPTAC: A degradation platform via directly targeting proteasomeJ. Acta Pharmaceutica Sinica B, 2025, 15(1): 661-664. DOI: 10.1016/j.apsb.2024.09.003
|